» Articles » PMID: 6129301

Role of Lipoproteins and Erythrocytes in the in Vitro Binding and Distribution of Cyclosporin A in the Blood

Overview
Specialties Pharmacology
Pharmacy
Date 1982 Nov 1
PMID 6129301
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The distribution of cyclosporin A between plasma, leucocytes and erythrocytes was studied in vitro by means of sedimentation in Ficoll-Paque and dextran. The uptake by erythrocytes was found to be about 50% and the fraction of cyclosporin A bound to leucocytes amounted to 15%. Fractionation of plasma by ultracentrifugation also showed that two thirds of the drug were associated with lipoproteins whereas binding studies with isolated lipoproteins and plasma also indicated that lipoproteins were the major complexing constituents for cyclosporin A in plasma. The binding of cyclosporin A to erythrocytes and lipoproteins seems to be a linear process. The binding to the leucocytes may be a saturable process, however it is of minor importance in terms of the overall binding capacity in the blood.

Citing Articles

Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated F-fluorination of boroxines, in vitro and initial in vivo evaluation.

Bolik K, Hellmann J, Maschauer S, Neu E, Einsiedel J, Riss P EJNMMI Res. 2024; 14(1):80.

PMID: 39231867 PMC: 11374953. DOI: 10.1186/s13550-024-01141-2.


Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients.

Zwart T, Metscher E, van der Boog P, Swen J, De Fijter J, Guchelaar H Br J Clin Pharmacol. 2022; 88(11):4854-4869.

PMID: 35670960 PMC: 9796409. DOI: 10.1111/bcp.15433.


Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs.

Mochizuki T, Aoki Y, Yoshikado T, Yoshida K, Lai Y, Hirabayashi H Clin Transl Sci. 2022; 15(6):1519-1531.

PMID: 35421902 PMC: 9199885. DOI: 10.1111/cts.13272.


Analysis of the variable factors affecting changes in the blood concentration of cyclosporine before and after transfusion of red blood cell concentrate.

Uchida M, Hanada N, Yamazaki S, Takatsuka H, Imai C, Utsumi A J Pharm Health Care Sci. 2022; 8(1):4.

PMID: 35101135 PMC: 8805225. DOI: 10.1186/s40780-021-00235-6.


Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients.

Job K, Roberts J, Enioutina E, Illamola S, Kumar S, Rashid J Expert Opin Drug Metab Toxicol. 2021; 17(7):747-765.

PMID: 34121566 PMC: 10726690. DOI: 10.1080/17425255.2021.1943356.